Pharma Uncategorized

J&J acquires cardio tech maker Abiomed for $16.6bn

J&J acquires cardiovascular medtech developer Abiomed for $16.6 billion

Read More
Drugs Pharma

Verge Genomics starts human trials with AI drug

Verge Genomics, backed by Eli Lilly and Merck & Co., announced it had dosed a human during clinical trials with a drug discovered.

Read More
Health Pharma

Dearth of Philips MRI-guided breast biopsy plates hit US

The FDA has told healthcare providers to consider different MRI-guided breast biopsy procedure options due to a shortage of grid plates and coil.

Read More
Climate Pharma

Best Agrolife gets Indian patent for fungicidal composition

HQ Team October 31, 2022: Best Agrolife, a BSE-listed company, announced that its subsidiary had received a patent from the Indian government to.

Read More
Drugs Pharma

EMA cracks the whip on JAK inhibitors for inflammatory disorders

The European Medicines Agency has suggested steps to minimize the risk of severe side effects associated with Janus kinase (JAK) inhibitors, used to.

Read More
Health Pharma

2seventy bio, China’s JW Therapeutics sign pact for cancer therapy

2seventy bio, Inc., an immuno-oncology cell therapy company, and China’s JW Therapeutics, announced a pact to establish a platform to explore T cell-based.

Read More
Pharma

Glenmark’s India facility gets ‘import alert’ from USFDA

Glenmark Pharmaceuticals, an Indian biopharmaceutical company, has received an "import alert" from USFDA for its Baddi facility in Himachal Pradesh.

Read More
Drugs Pharma

Alembic gets USFDA nod for oncology injection Paclitaxel

Alembic Pharmaceuticals, an Indian maker of generic drugs, announced it had received USFDA's final approval for Paclitaxel injection multi-dose vials for use in.

Read More
Health Pharma

Tuberculosis claims 1.6 million people in 2021, WHO says

Tuberculosis, the second deadliest infectious killer after Covid-19, claimed 1.6 million lives last year, including 187,000 HIV-positive patients, according to the WHO's 2022.

Read More
Drugs Pharma

J&J gets FDA approval for therapy to treat blood cancer

J &J gets approval from FDA for medicine to treat a type of blood cancer-Multiple Myeloma

Read More